title: Ivermectin treatment in severe asymmetric reactive onchodermatitis (sowda) in Sudan.
abstract: Ivermectin efficacy and post-treatment reactions in asymmetric severe reactive ochodermatitis (sowda) were studied in 8 patients with sowda syndrome and 6 with mild generalized onchodermatitis in Sudan. Initial skin snips from 12 patients contained microfilariae (1-9 per mg skin). Patients were treated in hospital with a single oral dose of c. 150 micrograms/kg ivermectin (103-200 micrograms/kg) and monitored for frequency and severity of post-treatment reactions for 4 weeks. Serial samples of heparinized blood were collected over the first 24 h after treatment for determination of ivermectin pharmacokinetics. Skin snips from all patients on days 3 and 28 revealed no microfilariae. Post-treatment reactions were more common and severe in individuals with sowda; they consisted mainly of musculoskeletal pain, local swellings with pitting oedema, and lymph gland tenderness and enlargement. No relation was established between these reactions, the microfilarial infection intensity, or the plasma pharmacokinetic profiles. A single oral dose of ivermectin cleared the skin of microfilariae and led to improvement of symptoms and dermatological signs of sowda, but resulted in more marked reactions than in cases of generalized onchodermatitis.
authors.affiliation: Department of Medicine, Faculty of Medicine, University of Khartoum, Sudan.
authors.forename: O Z
authors.initials: OZ
authors.lastname: Baraka
authors.forename: B M
authors.initials: BM
authors.lastname: Mahmoud
authors.forename: M M
authors.initials: MM
authors.lastname: Ali
authors.forename: M H
authors.initials: MH
authors.lastname: Ali
authors.forename: E A
authors.initials: EA
authors.lastname: el Sheikh
authors.forename: M M
authors.initials: MM
authors.lastname: Homeida
authors.forename: C D
authors.initials: CD
authors.lastname: Mackenzie
authors.forename: J F
authors.initials: JF
authors.lastname: Williams
mesh_terms: D000293:Adolescent; D000328:Adult; D000818:Animals; D000977:Antiparasitic Agents; D005260:Female; D006801:Humans; D007559:Ivermectin / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D017181:Onchocerca volvulus; D009855:Onchocerciasis / Q000188:drug therapy* / Q000473:pathology; D012876:Skin Diseases, Parasitic / Q000469:parasitology / Q000473:pathology; D013397:Sudan
chemical_list: D000977:Antiparasitic Agents; D007559:Ivermectin